Evidence map›Paper›PMID 30245249›Full record

Trial reportJournal of affective disorders2019

Pretreatment brain connectivity during positive emotion upregulation predicts decreased anhedonia following behavioral activation therapy for depression.

Erin C Walsh, Tory A Eisenlohr-Moul, Jared Minkel, Joshua Bizzell, Chris Petty, Andrew Crowther, Hannah Carl, Moria J Smoski, Gabriel S Dichter

Registry-linked trialOpen access · greenAbstract readClinical Trial
In one paragraph

Trial report in Journal of affective disorders, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05282277 (Examining the Effects of Estradiol on Neural and Molecular Response to Rewards in Perimenopausal-Onset Anhedonia and Psychosis), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05282277 phase4recruitingnot on this mapstarted 2022, after this paper: background citation

Examining the Effects of Estradiol on Neural and Molecular Response to Rewards in Perimenopausal-Onset Anhedonia and Psychosis

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2022 to 2026Enrolled103ConditionsDepression, Psychosis, AnhedoniaArmsTransdermal Estradiol, Micronized Progesterone, Matching Placebo Patch, Raclopride C11
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Breakthroughs and challenges for generating brain network-based biomarkers of treatment response in depression.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  4. Behavioral Activation and Brain Network Changes in Depression.Journal of clinical neurology (Seoul, Korea) · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Task MRI-Based Functional Brain Network of Major Depression.Advances in experimental medicine and biology · 2021
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Erin C WalshDepartment of Psychiatry, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.
Tory A Eisenlohr-MoulDepartment of Psychiatry, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Department of Psychiatry, University of Illinois at Chicago, Neuropsychiatry Institute, Chicago, IL 60612, USA.
Jared MinkelDepartment of Psychiatry, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA.
Joshua BizzellDuke-UNC Brain Imaging and Analysis Center, Duke University Medical Center, Durham, NC 27710, USA; UNC Neurobiology Curriculum, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.
Chris PettyDuke-UNC Brain Imaging and Analysis Center, Duke University Medical Center, Durham, NC 27710, USA.
Andrew CrowtherUNC Neurobiology Curriculum, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.
Hannah CarlDepartment of Psychology & Neuroscience, Duke University, Durham, NC 27710, USA.
Moria J SmoskiDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA.
Gabriel S DichterDepartment of Psychiatry, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Carolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA. Electronic address: dichter@med.unc.edu.
University of North Carolina at Chapel Hill · USDuke Medical Center · USDuke University · US

Funding

Preclinical CoreU54HD079124 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BELGER, AYSENIL · 2013 to 2019
$8.0M
North Carolina Translational & Clinical Sciences Institute (NC TraCS)KL2TR001109 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, CAREY, TIMOTHY S · 2013 to 2017
$5.7M
Postdoctoral Training in Reproductive Mood DisordersT32MH093315 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SUSAN Scott GIRDLER, David R. Rubinow · 2012 to 2026
$2.8M
Neuroinflammatory Mechanisms of Anhedonia in Major DepressionK23MH113733 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WALSH, ERIN · 2018 to 2023
$866k
Functional Neuroimaging of Psychopharmacologic Intervention for AutismK23MH081285 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DICHTER, GABRIEL S · 2008 to 2012
$794k
Ovarian Hormone Withdrawal and Suicide Risk: An Experimental ApproachR00MH109667 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI EISENLOHR-MOUL, TORY ANNE · 2018 to 2020
$747k
Emotion Regulation in Late-Life Depression: Effectiveness and Neural MechanismsK23MH087754 · NIMH · DUKE UNIVERSITY · PI SMOSKI, MORIA J. · 2009 to 2013
$684k
A Compute Cluster for Brain Imaging and AnalysisS10OD021480 · OD · DUKE UNIVERSITY · PI SONG, ALLEN W · 2016 to 2016
$568k
Imaging Genetic Predictors of Psychotherapy Outcomes in Unipolar DepressionR21MH094781 · NIMH · DUKE UNIVERSITY · PI DICHTER, GABRIEL S, SMOSKI, MORIA J. · 2012 to 2013
$492k
Ovarian Hormone Withdrawal and Suicide Risk: An Experimental ApproachK99MH109667 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI EISENLOHR-MOUL, TORY ANNE · 2016 to 2017
$164k
NCATS NIH HHS KL2 TR001109NICHD NIH HHS U54 HD079124NIH HHS S10 OD021480NIMH NIH HHS K23 MH081285NIMH NIH HHS K23 MH087754NIMH NIH HHS K23 MH113733NIMH NIH HHS K99 MH109667NIMH NIH HHS R00 MH109667NIMH NIH HHS R21 MH094781NIMH NIH HHS T32 MH093315
6 · The paper itself

Abstract

backgroundNeurobiological predictors of antidepressant response may help guide treatment selection and improve response rates to available treatments for major depressive disorder (MDD). Behavioral activation therapy for depression (BATD) is an evidence-based intervention designed to ameliorate core symptoms of MDD by promoting sustained engagement with value-guided, positively-reinforcing activities. The present study examined pre-treatment task-based functional brain connectivity as a predictor of antidepressant response to BATD.

methodsThirty-three outpatients with MDD and 20 nondepressed controls completed a positive emotion regulation task during fMRI after which participants with MDD received up to 15 sessions of BATD. We used generalized psychophysiological interaction analyses to examine group differences in pre-treatment functional brain connectivity during intentional upregulation of positive emotion to positive images. Hierarchical linear models were used to examine whether group differences in functional connectivity predicted changes in depression and anhedonia over the course of BATD.

resultsCompared to controls, participants with MDD exhibited decreased connectivity between the left middle frontal gyrus and right temporoparietal regions during upregulation of positive emotion. Within the MDD group, decreased connectivity of these regions predicted greater declines in anhedonia symptoms over treatment. LIMITATIONS: Future studies should include comparison treatments and longitudinal follow-up to clarify the unique effects of BATD on neural function and antidepressant response.

conclusionsResults are consistent with previous work showing BATD may be particularly effective for individuals with greater disturbances in brain reward network function, but extend these findings to highlight the importance of frontotemporoparietal connectivity in targeting symptoms of low motivation and engagement.

Indexed as

AnhedoniaApplied Behavior AnalysisPredictive Value of TestsAdultCerebral CortexEmotionsFemaleFunctional NeuroimagingHumansMagnetic Resonance ImagingMajor Depressive DisorderMaleMiddle AgedYoung AdultBehavioral activation therapyfMRIFunctional brain connectivityMajor depressionPositive emotion regulation

Identifiers

PMID30245249
PMCPMC6411035
OpenAlexW2891749380

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.